Detalles de la búsqueda
1.
A randomized, controlled, repeat-dose study of batefenterol/fluticasone furoate compared with placebo in the treatment of COPD.
BMC Pulm Med;
20(1): 119, 2020 May 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32366249
2.
Both acute and chronic inflammation are associated with less perineural invasion in men with prostate cancer on repeat biopsy.
BJU Int;
123(1): 91-97, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29873889
3.
Sleep Problems are Associated with Development and Progression of Lower Urinary Tract Symptoms: Results from REDUCE.
J Urol;
199(2): 536-542, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-28870861
4.
Prostate cancer detection using quantitative T2 and T2 -weighted imaging: The effects of 5-alpha-reductase inhibitors in men on active surveillance.
J Magn Reson Imaging;
47(6): 1646-1653, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29135073
5.
Chronic Prostate Inflammation Predicts Symptom Progression in Patients with Chronic Prostatitis/Chronic Pelvic Pain.
J Urol;
198(1): 122-128, 2017 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-28089730
6.
Does Peak Urine Flow Rate Predict the Development of Incident Lower Urinary Tract Symptoms in Men with Mild to No Current Symptoms? Results from REDUCE.
J Urol;
198(3): 650-656, 2017 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-28428110
7.
Dutasteride is associated with reduced risk of transrectal prostate biopsy-associated urinary tract infection and related hospitalizations.
World J Urol;
35(10): 1525-1530, 2017 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-28396999
8.
Serum cholesterol and risk of lower urinary tract symptoms progression: Results from the Reduction by Dutasteride of Prostate Cancer Events study.
Int J Urol;
24(2): 151-156, 2017 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-28004415
9.
Chronic Prostate Inflammation is Associated with Severity and Progression of Benign Prostatic Hyperplasia, Lower Urinary Tract Symptoms and Risk of Acute Urinary Retention.
J Urol;
196(5): 1493-1498, 2016 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-27378134
10.
The Association between Phosphodiesterase Type 5 Inhibitors and Prostate Cancer: Results from the REDUCE Study.
J Urol;
196(3): 715-20, 2016 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-27060053
11.
Chronic baseline prostate inflammation is associated with lower tumor volume in men with prostate cancer on repeat biopsy: Results from the REDUCE study.
Prostate;
75(13): 1492-8, 2015 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-26184556
12.
Does Obesity Modify the Ability of Prebiopsy Prostate Specific Antigen to Detect Prostate Cancer on Repeat Biopsy? Results from the REDUCE Study.
J Urol;
194(1): 52-7, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-25661298
13.
Baseline Prostate Atrophy is Associated with Reduced Risk of Prostate Cancer in Men Undergoing Repeat Prostate Biopsy.
J Urol;
194(5): 1241-6, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26165588
14.
Metabolic syndrome-like components and prostate cancer risk: results from the Reduction by Dutasteride of Prostate Cancer Events (REDUCE) study.
BJU Int;
115(5): 736-43, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-24931061
15.
Baseline prostate inflammation is associated with a reduced risk of prostate cancer in men undergoing repeat prostate biopsy: results from the REDUCE study.
Cancer;
120(2): 190-6, 2014 Jan 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-24323568
16.
Asian Race and Risk of Prostate Cancer: Results from the REDUCE Study.
Cancer Epidemiol Biomarkers Prev;
29(11): 2165-2170, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32856605
17.
Randomized dose-finding study of batefenterol via dry powder inhaler in patients with COPD.
Int J Chron Obstruct Pulmon Dis;
14: 615-629, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30880951
18.
Baseline prostate atrophy is associated with lower tumor volume in men with prostate cancer on repeat biopsy.
Prostate Cancer Prostatic Dis;
21(1): 106-112, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29203895
19.
Serum cholesterol and risk of high-grade prostate cancer: results from the REDUCE study.
Prostate Cancer Prostatic Dis;
21(2): 252-259, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29282360
20.
Geographic Differences in Baseline Prostate Inflammation and Relationship with Subsequent Prostate Cancer Risk: Results from the Multinational REDUCE Trial.
Cancer Epidemiol Biomarkers Prev;
27(7): 783-789, 2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29669727